Contributors

AmirAbdollahi

German Cancer Consortium (DKTK), Heidelberg, Germany

Molecular & Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology (HIRO), University of Heidelberg Medical School and National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany

Baltazar D.Aguda,     DiseasePathways LLC, Bethesda, MD, USA

ShadanAli,     Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA

Osama M.Alian,     Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA

Laufey T.Amundadottir,     Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Asfar S.Azmi,     Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA

Ginny F.Bao,     Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA

Oliver F.Bathe,     Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada

Charles E.Birse,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; Celera, Alameda, CA, USA

Teresa A.Brentnall,     Department of Medicine, University of Washington, Seattle, WA, USA

RuChen,     Department of Medicine, University of Washington, Seattle, WA, USA

EdmundClarke,     Computer Science Department, Carnegie Mellon University, Pittsburgh, PA, USA

BrunoDomon,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; Luxembourg Clinical Proteomics Center, CRP-Sante, Luxembourg

NiccolaFunel,     Department of Surgical, Molecular and Medical Pathology, University of Pisa, Pisa, Italy

JiankunGao,     Department of Basic Medical Sciences, Sichuan College of Traditional Chinese Medicine, Mianyang, Sichuan, China

HaijunGong,     Department of Mathematics and Computer Science, Saint Louis University, St. Louis, MO, USA

RobertGrützmann,     Department of General, Thoracic, and Vascular Surgery, University Hospital “Carl Gustav Carus”, Dresden University of Technology, Dresden, Germany

TaoHe,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; Pfizer, Cambridge, MA, USA

JasonHoskins,     Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Sun-IlHwang,     Proteomics and Mass Spectrometry Research Laboratory, Carolinas HealthCare System, Charlotte, NC, USA

JinpingJia,     Laboratory ofTranslational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Amin I.Kassis,     Department of Radiology, Harvard Medical School, Boston, MA, USA

Jin-GyunLee,     Proteomics and Mass Spectrometry Research Laboratory, Carolinas HealthCare System, Charlotte, NC, USA

Candy N.Lee,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; Pfizer, South San Francisco, CA, USA

Lance A.Liotta,     Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

Kenneth E.Lipson,     FibroGen, Inc., San Francisco, CA, USA

IanMcCaffrey,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; Genentech, South San Francisco, CA, USA

Kimberly Q.McKinney,     Proteomics and Mass Spectrometry Research Laboratory, Carolinas HealthCare System, Charlotte, NC, USA

KatherineMcKinnon,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; NCI, Bethesda, MD, USA

LucioMiele,     University of Mississippi Cancer Institute, Jackson, MS, USA

Ramzi M.Mohammad,     Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA; Hamad Medical Corporation, Doha, Qatar

Paul A.Moore,     Department of Protein Therapeutics, Celera, Rockville, MD, USA; MacroGenics Inc., Rockville, MD, USA

IrfanaMuqbil,     Department of Biochemistry, Faculty of Life Sciences, AMU, Aligarh, UP, India

ShengPan,     Department of Medicine, University of Washington, Seattle, WA, USA

Emanuel F.PetricoinIII.,     Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

Philip A.Philip,     Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA

MariaelenaPierobon,     Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

ChristianPilarsky,     Department of Visceral-, Thoracic- and Vascular Surgery, Medizinische Universität Carl Gustav Carus, TU Dresden, Dresden, Germany

PavelPospisil,     Philip Morris International R&D, Philip Morris Products S.A., Neuchâtel, Switzerland

Francisco X.Real,     Spanish National Cancer Research Center (CNIO), Madrid, Spain

Steven M.Ruben,     Department of Protein Therapeutics, Celera, Rockville, MD, USA

Enrique Carrillo-deSanta Pau,     Spanish National Cancer Research Center (CNIO), Madrid, Spain

Fazlul H.Sarkar,     Department of Pathology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI,...